MedTech Industry Dynamics
MedTech Industry Dynamics
Metriport has raised $26 million in new funding led by Matrix, with participation from ARTIS and Y Combinator, to expand its open-source data infrastructure platform that transforms fragmented patient records into structured, actionable information for clinicians at the point of care.
詳細情報Shape Memory Medical has closed a $10 million convertible note financing led by August Global Partners, with participation from Taiwania Capital, to support clinical development of its aortic portfolio including the AAA-SHAPE Pivotal Trial and FLAGSHIP feasibility study.
詳細情報CHN-WIN Health has secured a Series A financing round led by Efung Zhuohua Fund to advance its first-in-class Neuro-IVUS system for cerebrovascular intervention through clinical trials and NMPA regulatory submission, addressing a critical gap in intracranial imaging.
詳細情報MaxQ Medicalは、Atlantic Blue Ventures、S3 Ventures、Olympus Innovation Venturesが主導する3150万ドルのシリーズA資金調達ラウンドを完了し、良性前立腺過形成症および前立腺癌に対する経尿道イメージング・治療システムを前進させる。
詳細情報Renata Medicalは、ARCHIMEDが主導する2500万ドルのシリーズD資金調達ラウンドを完了し、Minimaステントシステムの米国および国際的な商業化を加速し、小児先天性心疾患専用技術のパイプラインを推進する。
詳細情報Enginprime Medical has closed a $12 million Series A financing round led exclusively by Qiming Venture Partners to fund the China registration trial for its OpusOne percutaneous ventricular assist device and support early-stage clinical development globally.
詳細情報UNC Health has rebranded Rex Health Ventures as UNC Health Ventures, a corporate venture capital and strategic investment platform that will partner with emerging healthcare companies to support better care, operational efficiency, and long-term value creation.
詳細情報Clarevia Ventures has appointed Cheryl R. Blanchard, Ph.D., former President and CEO of Anika Therapeutics, as Executive in Residence, where she will advise portfolio companies and evaluate emerging opportunities in healthcare.
詳細情報CoreMapは、メドトロニックが主導する3700万ドルのオーバーサブスクライブシリーズC資金調達ラウンドを完了し、次世代心房細動マッピングプラットフォームの開発と市場投入を加速する。
詳細情報Navi Medical Technologies has raised A$6.8 million in a round led by KP Rx to commercialize its Neonav ECG-guided vascular access device in the United States, following FDA clearance and clinical evaluations at leading U.S. children’s hospitals.
詳細情報
